These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37190077)

  • 41. Stable DNMT3L overexpression in SH-SY5Y neurons recreates a facet of the genome-wide Down syndrome DNA methylation signature.
    Laufer BI; Gomez JA; Jianu JM; LaSalle JM
    Epigenetics Chromatin; 2021 Mar; 14(1):13. PubMed ID: 33750431
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Methylomic profiling in trisomy 21 identifies cognition- and Alzheimer's disease-related dysregulation.
    Haertle L; Müller T; Lardenoije R; Maierhofer A; Dittrich M; Riemens RJM; Stora S; Roche M; Leber M; Riedel-Heller S; Wagner M; Scherer M; Ravel A; Mircher C; Cieuta-Walti C; Durand S; van de Hove DLA; Hoffmann P; Ramirez A; Haaf T; El Hajj N; Mégarbané A
    Clin Epigenetics; 2019 Dec; 11(1):195. PubMed ID: 31843015
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Altered cell and RNA isoform diversity in aging Down syndrome brains.
    Palmer CR; Liu CS; Romanow WJ; Lee MH; Chun J
    Proc Natl Acad Sci U S A; 2021 Nov; 118(47):. PubMed ID: 34795060
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Potential Role of JAK-STAT Signaling Pathway in the Neurogenic-to-Gliogenic Shift in Down Syndrome Brain.
    Lee HC; Tan KL; Cheah PS; Ling KH
    Neural Plast; 2016; 2016():7434191. PubMed ID: 26881131
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of fetal unmodified and 5-hydroxymethylated CG sites in maternal cell-free DNA for non-invasive prenatal testing.
    Gordevičius J; Narmontė M; Gibas P; Kvederavičiūtė K; Tomkutė V; Paluoja P; Krjutškov K; Salumets A; Kriukienė E
    Clin Epigenetics; 2020 Oct; 12(1):153. PubMed ID: 33081811
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The burden of trisomy 21 disrupts the proteostasis network in Down syndrome.
    Aivazidis S; Coughlan CM; Rauniyar AK; Jiang H; Liggett LA; Maclean KN; Roede JR
    PLoS One; 2017; 12(4):e0176307. PubMed ID: 28430800
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evidence against the overexpression of APP in Down syndrome.
    Argellati F; Massone S; d'Abramo C; Marinari UM; Pronzato MA; Domenicotti C; Ricciarelli R
    IUBMB Life; 2006 Feb; 58(2):103-6. PubMed ID: 16608822
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Down syndrome--genetic and nutritional aspects of accompanying disorders.
    Mazurek D; Wyka J
    Rocz Panstw Zakl Hig; 2015; 66(3):189-94. PubMed ID: 26400113
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alterations of epigenetic landscape in Down syndrome carrying pregnancies: A systematic review of case-control studies.
    Reza Karimzadeh M; Ehtesham N; Mortazavi D; Azhdari S; Mosallaei M; Nezamnia M
    Eur J Obstet Gynecol Reprod Biol; 2021 Sep; 264():189-199. PubMed ID: 34325214
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterising the brain metalloproteome in Down syndrome patients with concomitant Alzheimer's pathology.
    Malakooti N; Roberts B; Pritchard MA; Volitakis I; Kim RC; Lott IT; McLean CA; Finkelstein DI; Adlard PA
    Metallomics; 2020 Jan; 12(1):114-132. PubMed ID: 31764918
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cell cycle alteration and decreased cell proliferation in the hippocampal dentate gyrus and in the neocortical germinal matrix of fetuses with Down syndrome and in Ts65Dn mice.
    Contestabile A; Fila T; Ceccarelli C; Bonasoni P; Bonapace L; Santini D; Bartesaghi R; Ciani E
    Hippocampus; 2007; 17(8):665-78. PubMed ID: 17546680
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Three Copies of Four Interferon Receptor Genes Underlie a Mild Type I Interferonopathy in Down Syndrome.
    Kong XF; Worley L; Rinchai D; Bondet V; Jithesh PV; Goulet M; Nonnotte E; Rebillat AS; Conte M; Mircher C; Gürtler N; Liu L; Migaud M; Elanbari M; Habib T; Ma CS; Bustamante J; Abel L; Ravel A; Lyonnet S; Munnich A; Duffy D; Chaussabel D; Casanova JL; Tangye SG; Boisson-Dupuis S; Puel A
    J Clin Immunol; 2020 Aug; 40(6):807-819. PubMed ID: 32572726
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impaired brain glucose metabolism in patients with Down syndrome.
    Labudova O; Cairns N; Kitzmüller E; Lubec G
    J Neural Transm Suppl; 1999; 57():247-56. PubMed ID: 10666680
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Protein levels of genes encoded on chromosome 21 in fetal Down Syndrome brain (Part V): overexpression of phosphatidyl-inositol-glycan class P protein (DSCR5).
    Ferrando-Miguel R; Cheon MS; Lubec G
    Amino Acids; 2004 Jun; 26(3):255-61. PubMed ID: 15221505
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Investigating the impact of Down syndrome on methylation and glycomics with two-stage PO2PLS.
    Gu Z; El Bouhaddani S; Houwing-Duistermaat J; Uh HW
    Theor Biol Forum; 2021 Jan; 114(1-2):29-44. PubMed ID: 35502729
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Down Syndrome, Ageing and Epigenetics.
    Gensous N; Franceschi C; Salvioli S; Garagnani P; Bacalini MG
    Subcell Biochem; 2019; 91():161-193. PubMed ID: 30888653
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Overexpression of transcription factor BACH1 in fetal Down syndrome brain.
    Ferrando-Miguel R; Cheon MS; Yang JW; Lubec G
    J Neural Transm Suppl; 2003; (67):193-205. PubMed ID: 15068251
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Overexpression of FABP7 in Down syndrome fetal brains is associated with PKNOX1 gene-dosage imbalance.
    Sánchez-Font MF; Bosch-Comas A; Gonzàlez-Duarte R; Marfany G
    Nucleic Acids Res; 2003 Jun; 31(11):2769-77. PubMed ID: 12771203
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cell-type deconvolution from DNA methylation: a review of recent applications.
    Titus AJ; Gallimore RM; Salas LA; Christensen BC
    Hum Mol Genet; 2017 Oct; 26(R2):R216-R224. PubMed ID: 28977446
    [TBL] [Abstract][Full Text] [Related]  

  • 60. REST Targets JAK-STAT and HIF-1 Signaling Pathways in Human Down Syndrome Brain and Neural Cells.
    Huang T; Fakurazi S; Cheah PS; Ling KH
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.